Trial Profile
Study of AQS1302 in epilepsy patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 18 Feb 2016
Price :
$35
*
At a glance
- Drugs Clobazam (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors Aequus Pharmaceuticals
- 18 Feb 2016 New trial record